Skip to main content
Year archive

DBV Technologies — 2013 filings

All 23 regulatory filings released by DBV Technologies (DBV) in 2013, sourced directly from the official regulator.

23 Filings
2013 Period
2013 filings (23)
Filing Released Lang
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
Share Issue/Capital Change
2013-07-08 French
DBV Technologies Monthly information regarding the total number of voting rights and total number of shares of the Company
Share Issue/Capital Change
2013-07-08 English
DBV Technologies annonce la fin du recrutement de l'étude clinique internationale de phase IIb VIPES
Regulatory Filings
2013-07-08 French
DBV Technologies completes enrollment of Phase IIb VIPES study, the first-ever global trial in desensitization to peanut allergy
Regulatory Filings
2013-07-08 English
DBV Technologies : Half year update on the DBV Technologies liquidity agreement
Net Asset Value
2013-07-05 English
DBV Technologies : Bilan semestriel du contrat de liquidité DBV Technologies
Regulatory Filings
2013-07-05 French
DBV Technologies a présenté des données de premier plan lors du congrès de l'EAACI-WAO
Regulatory Filings
2013-06-28 French
DBV Technologies announces breakthrough Data Presentations at EAACI-WAO Congress
Regulatory Filings
2013-06-28 English
DBV Technologies : Viaskin Peanut demonstrates strong efficacy trend in severely peanut-allergic children in 18-month results of ARACHILD pilot study
Regulatory Filings
2013-06-20 English
DBV Technologies : L'étude pilote Arachild met en évidence l'efficacité de Viaskin® Peanut chez l'enfant sévèrement allergique à l'arachide après 18 mois de traitement
Regulatory Filings
2013-06-20 French
DBV Technologies proudly welcomes Mrs. Veronique Foutel as Chief Strategic Marketing Officer
Board/Management Information
2013-06-06 English
DBV Technologies se félicite de l'arrivée de Véronique Foutel en tant que Directrice Marketing Stratégique
Board/Management Information
2013-06-06 French
Assemblée Générale Mixte des Actionnaires de la société DBV Technologies du 4 juin 2013
AGM Information
2013-06-04 French
DBV Technologies' June 4th, 2013 Combined Shareholders's Meeting
AGM Information
2013-06-04 English
DBV Technologies et Stallergenes s'associent pour développer des traitements innovants contre les allergies respiratoires
Regulatory Filings
2013-05-16 French
DBV Technologies and Stallergenes enter into partnership for the development of innovative treatment of respiratory allergies
Regulatory Filings
2013-05-16 English
ASSEMBLEE GENERALE MIXTE DU 4 JUIN 2013 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
AGM Information
2013-05-14 French
DBV Technologies et l'Hôpital Mount Sinai concluent un accord de collaboration de recherche
Regulatory Filings
2013-05-07 French
DBV Technologies and Mount Sinai Hospital enter into a Research Collaboration Agreement
Regulatory Filings
2013-05-07 English
DBV Technologies publishes its 2012 Registration Document and its 2012 Annual Financial Report
Report Publication Announcement
2013-04-25 English
DBV Technologies publie son document de référence et son Rapport Financier Annuel 2012
Report Publication Announcement
2013-04-25 French
DBV Technologies' first quarter 2013 Topline and cash position
Earnings Release Q1 2013
2013-04-15 English
Chiffre d'affaires et position de trésorerie de DBV Technologies pour les trois premiers mois de l'année 2013
Earnings Release Q1 2013
2013-04-15 French